美國居民不適用 XM 服務。
I
I

Illumina

交易方向

交易者脈動

技術摘要

小時

財經新聞

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Hess, U.S. Steel and Paramount Global April 12 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2 000 GMT on Friday: * * Hedge fund Barington Capital urged Paramount Global to scrap its exclusive merger talks with Skydance Media, arguing all shareholders would benefit if the company looked at other potential bidders.
B
C
I
S
U
B

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Illumina, Central Group April 12 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Friday: ** U.S. gene sequencing company Illumina's ILMN.O plan to divest cancer diagnostic test maker Grail GRAL.O received the green light from EU antitrust regulators after having blocked the deal two years ago.
B
I
S
B

EU approves Illumina's plan to divest cancer test maker Grail

UPDATE 2-EU approves Illumina's plan to divest cancer test maker Grail Adds Illumina's statement in paragraph 2 and 7, details in paragraphs 10 to 12 By Foo Yun Chee BRUSSELS, April 12 (Reuters) - U.S. gene sequencing company Illumina's ILMN.O plan to divest cancer diagnostic test maker Grail GRAL.O received the green light from EU antitrust regulators on Friday after having blocked the deal two years ago.
I

EU approves Illumina's plan to divest cancer test maker Grail

EU approves Illumina's plan to divest cancer test maker Grail BRUSSELS, April 12 (Reuters) - The EU's executive Commission approved Illumina's ILMN.O plan to unwind its completed acquisition of cancer diagnostic test maker Grail GRAL.O , it said in a statement on Friday. The U.S. gene sequencing company Illumina had announced late last year to divest Grail, after the companies battled both U.S.
I

Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed

UPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed Adds details in paragraph 3, background in paragraphs 5-6 April 9 (Reuters) - Illumina ILMN.O said on Tuesday Chief Financial Officer Joydeep Goswami will leave the gene sequencing company and be succeeded by former Summit Therapeutics' SMMT.O executive Ankur Dhingra.
A
I

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明